Incyte 2022 First Quarter Financial and Corporate Update MAY 3, 2022 ■ 官网 | 【国 . - - - - - - - - 000 0000000 Forward-Looking Statements 2 Except for the historical information set forth herein, the matters set forth in this presentation contain predictions, estimates and other forward-looking statements, including statements regarding: the opportunities for growth and diversification presented by Incyte's portfolio; our and our collaborators' potential for receiving regulatory approvals within the next 1-2 ...

Incyte Corporation (NASDAQ:INCY) Q1 2022 Earnings Conference Call May 3, 2022 8:00 AM ET Company Participants Christine Chiou – Head-Investor Relations Hervé Hoppenot – Chairman, President and Chief Executive Officer Barry Flannelly – Executive Vice President and General Manager-North America Steven Stein – Executive Vice President and Chief Medical Officer Christiana Stamoulis – Executive Vice President and Chief Financial Officer Conference Call Participants Vikram Purohit – Morgan Stanley Kripa Devarakon ...

Incyte Corporation (NASDAQ:INCY) Q4 2021 Earnings Conference Call February 8, 2022 8:00 AM ET Company Participants Christine Chiou – Head-Investor Relations Hervé Hoppenot – Chairman, President and Chief Executive Officer Barry Flannelly – Executive Vice President and General Manager-North America Steven Stein – Executive Vice President and Chief Medical Officer Christiana Stamoulis – Executive Vice President and Chief Financial Officer Conference Call Participants Vikram Purohit – Morgan Stanley Brian Abra ...

| --- | --- | --- | --- | --- | --- | --- | |---------------------------------------------------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Hervé Hoppenot, CEO | | | | | | | | JP MORGAN HEALTHCARE CONFERENCE JANUARY 10, 2022 | | | | | | | | | | | | | | | Forward-looking statements 2 Except for the historical information set forth herein, the matters set forth in this presentation contain predictions, estimates, and other forward-looking ...

| --- | --- | --- | --- | --- | --- | --- | --- | --- | |--------------------------------------------------------------------|-------|-------|------------------|--------|-------|-------|-------|-------| | | | | 官方 \| W | | | | | | | | | | . 000 00 10 100 | \| ■ ■ | | | | | | Incyte | | | | | | | | | | 2021 Third Quarter Financial and Corporate Update NOVEMBER 2, 2021 | | | | | | | | | | | | | | | | | | | FORWARD-LOOKING STATEMENTS 2 Except for the historical information set forth herein, the matters set for ...

Incyte Corporation (NASDAQ:INCY) Q3 2021 Earnings Conference Call November 2, 2021 8:00 AM ET Company Participants Christine Chiou – Head of Investor Relations Herve Hoppenot – Chairman and Chief Executive Officer Barry Flannelly – Executive Vice President Steven Stein – Chief Medical Officer Christiana Stamoulis – Chief Financial Officer Conference Call Participants Tazeen Ahmad – Bank of America Brian Abrahams – RBC Cory Kasimov – JP Morgan Kripa Devarakonda – Truist Securities Salveen Rachael – Goldman S ...

| --- | --- | --- | --- | --- | --- | --- | --- | |--------------------------------------------------|-------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | SOLVE Incyte) ON. GVHD UPDATE SEPTEMBER 27, 2021 | | | | | | | | | | | | | | | | | FORWARD LOOKING STATEMENTS 2 Except for the historical information set forth herein, the matters set forth in this presentation, including statements regarding the potential for growth and diversification of Incyte's revenues; the " ...

| --- | --- | --- | --- | --- | --- | --- | --- | |---------------------|-------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | OPZELURA TM | | | | | | | | | (ruxolitinib) cream | | | | | | | | | FDA Approval Call | | | | | | | | | SEPTEMBER 22, 2021 | | | | | | | | | | | | | | | | | FORWARD LOOKING STATEMENTS 2 Except for the historical information set forth he ...

Incyte Corporation (NASDAQ:INCY) Q2 2021 Earnings Conference Call August 3, 2021 8:00 AM ET Company Participants Christine Chiou - Senior Director, Investor Relations Hervé Hoppenot - Chairman, President and Chief Executive Officer Barry Flannelly - Executive Vice President and General Manager, North America Steven Stein - Executive Vice President and Chief Medical Officer Christiana Stamoulis - Executive Vice President and Chief Financial Officer Conference Call Participants Salveen Richter - Goldman Sachs ...

官方 | W ■ 000 E Incyte 2021 Second Quarter Financial and Corporate Update AUGUST 3, 2021 FORWARD-LOOKING STATEMENTS 2 Except for the historical information set forth herein, the matters set forth in this presentation contain predictions, estimates, and other forward-looking statements, including without limitation statements regarding: the potential approval and launch of tafasitamab (Minjuvi®) in Europe and the potential growth opportunities represented by such potential launch, the recent positive CHMP opi ...